All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | .... 39 Next >

Health Care Executive, Scholar and Vice Chancellor from UCLA, Dr. A. Eugene Washington, Appointed to Johnson & Johnson Board of Directors

November 09, 2012

Phase 3 Results Show Canagliflozin as Add-On Therapy to Metformin and Pioglitazone Significantly Lowers Blood Sugar Levels in Adult Patients with Type 2 Diabetes

November 09, 2012

S.M.A.R.T.® Vascular Stent Systems Receive FDA Approval for Use in SFA

November 08, 2012

Johnson & Johnson to Participate in Credit Suisse 2012 Healthcare Conference

November 07, 2012

Janssen Announces Collaboration With Vertex On Phase 2 Study To Investigate An All-Oral Regimen Of Simeprevir (Tmc435) And Vx-135 For Treatment Of Hepatitis C

November 05, 2012

FDA Approves XARELTO® (rivaroxaban) to Treat Deep Vein Thrombosis and Pulmonary Embolism, and to Reduce the Risk of Recurrent Events

November 02, 2012

< Prev | | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | .... 39 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.